N

NTRA

NTRA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
NTRA Live QuoteReal-time
$289.92
$123.46(-29.87%)1M
Day Range$288.20 – $307.19
Open$296.33
Previous Close$289.50
Volume2.74M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$43.36B
P/E Ratio (TTM)24.5
Forward P/E10000.0
EPS (TTM)$-1.12
Price to Book22.3
Dividend Yield0.65%
Beta (Volatility)1.51
IndustryDIAGNOSTICS & RESEARCH
52-Week RangeCurrent: $289.92 (42%)
Low: $181.00High: $437.41
Wall Street Consensus
Strong Buy
Analyst Rating
4.8/ 5.0
Target Price
$412.36+174.9% upside

Insider Buys

0

$0

Insider Sales

9

$70.37M

Total Volume

$70.37M

10 transactions

Net Activity

$70.37M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
R
1

Rabinowitz Matthew

Exec COB

0 buys3 sells

$55.45M total

S
2

Sheena Jonathan

CO-FOUNDER

0 buys3 sells

$8.78M total

C
3

Chapman Steven Leonard

CEO, Pres

0 buys2 sells

$3.95M total

M
4

Moshkevich Solomon

Pres, CLINICALDIAGNOSTICS

0 buys1 sells

$1.40M total

B
5

Brophy Michael Burkes

CFO

0 buys1 sells

$1.31M total

Trading History
NTRA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 11, 2026

1 weeks ago

Sheena Jonathan

CO-FOUNDER

Insider
Sell1.5K$319.30$479K

Nov 2, 2026

2 weeks ago

Chapman Steven Leonard

CEO, Pres

CEO
Sell3.8K$411.80$1.57M

Nov 2, 2026

2 weeks ago

Moshkevich Solomon

Pres, CLINICALDIAGNOSTICS

President
Sell3.4K$409.77$1.40M

Oct 28, 2026

3 weeks ago

Brophy Michael Burkes

CFO

CFO
Sell3.1K$425.90$1.31M

Oct 27, 2026

3 weeks ago

Chapman Steven Leonard

CEO, Pres

CEO
Sell5.7K$418.25$2.38M

Oct 21, 2026

1 months ago

Sheena Jonathan

CO-FOUNDER

Insider
Sell3.1K$410.55$1.29M

Oct 15, 2026

1 months ago

Rabinowitz Matthew

Exec COB

Insider
Sell50.0K$10.41$521K

Oct 15, 2026

1 months ago

Rabinowitz Matthew

Exec COB

Insider
Sell50.0K$402.64$20.13M

Sep 23, 2026

1 months ago

Sheena Jonathan

CO-FOUNDER

Insider
Sell18.1K$388.01$7.01M

Sep 14, 2026

2 months ago

Rabinowitz Matthew

Exec COB

Insider
Sell102.0K$341.15$34.80M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
NTRA Buy Conviction0%
Industry Rank#192 of 569
Volume Contribution0.4%
Total Industry Activity$16.52B

NTRA has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. NTRA ranks #192 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for NTRA

Over the last 90 days, corporate insiders at NTRA (NTRA) engaged in a total of 10 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 9 were sales. The total volume of insider trading reached $70.37M.

The net insider activity for NTRA shows a net selling bias of $70.37M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Rabinowitz Matthew (Exec COB), who traded 102.0K shares valued at $34.80M on Sep 14, 2026.

Live Market News & Developments
Aggregated real-time headlines for NTRA (NTRA)
6 updates

Natera, Inc. (NTRA) Stock Price, News, Quote & History

Yahoo! Finance CanadaYesterday

Natera, Inc. (NTRA) stock price, news, quote and history

Yahoo Finance UKYesterday

Why Is Natera Stock Up Nearly 41% Since May?

Trefis3d ago

UBS reiterates Natera stock rating on CEO transition confidence By Investing.com

Investing.com Canada6h ago

AI Takes On Cancer Detection From a Single Blood Draw (MEDS, ANT, GH, GRAL, NTRA, FRNM)

Benzinga4h ago

Weekly Recap: $6B 2029 revenue target and CFO projects $3B+ in 2026

TradingView4d ago

FAQs About NTRA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for NTRA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for NTRA is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 9 sales by company executives over the last 90 days.

The CEO Conviction Index for NTRA is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.